13537-141 NDC - ESIKA ()

Drug Information

  • Product NDC: 13537-141
  • Proprietary Name: ESIKA
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: Ventura Corporation Ltd.
Product Type:
FDA Application Number: M019
Marketing Category: OTC MONOGRAPH DRUG
Start Marketing Date:12/13/2011
End Marketing Date:12/31/2021

Package Information

No. Package Code Package Description Billing Unit
113537-141-0150 mL in 1 BOTTLE (13537-141-01)

NDC Record

Field Name Field Value Definition
PRODUCT NDC13537-141The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEESIKAThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXVANILLA SCENT Roll-OnThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
START MARKETING DATE12/13/2011The translation of the dosage form Code submitted by the firm.
END MARKETING DATE12/31/2021The translation of the route code submitted by the firm, indicating route of administration.
MARKETING CATEGORY NAMEOTC MONOGRAPH DRUGThis is the date that the labeler indicates was the start of its marketing of the drug product.
APPLICATION NUMBERM019Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEVentura Corporation Ltd.This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025

Previous Code
Next Code